228 related articles for article (PubMed ID: 6287082)
1. Persistence of transforming and nontransforming Epstein-Barr virus in high passages of P3HR-1 cell lines.
Gerber P; Ablashi D; Magrath I; Armstrong G; Andersen P; Trach L
J Natl Cancer Inst; 1982 Sep; 69(3):585-90. PubMed ID: 6287082
[TBL] [Abstract][Full Text] [Related]
2. Induction of an activated b lymphocyte-associated surface moiety defined by the B2 monoclonal antibody by ebv conversion of an EBV-negative lymphoma line (Ramos): differential effect of transforming (B95-8) and nontransforming (P3HR-1) EBV substrains.
Klein G; Ehlin-Henriksson B; Schlossman SF
J Immunol; 1983 Apr; 130(4):1985-9. PubMed ID: 6300235
[TBL] [Abstract][Full Text] [Related]
3. Identification of Epstein-Barr virus strain differences with monoclonal antibody to a membrane glycoprotein.
Qualtiere LF; Chase R; Vroman B; Pearson GR
Proc Natl Acad Sci U S A; 1982 Jan; 79(2):616-20. PubMed ID: 6176998
[TBL] [Abstract][Full Text] [Related]
4. B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas.
Yokochi T; Holly RD; Clark EA
J Immunol; 1982 Feb; 128(2):823-7. PubMed ID: 6274961
[TBL] [Abstract][Full Text] [Related]
5. Superinfection of epithelial hybrid cells (D98/HR-1, NPC-KT, and A2L/AH) with Epstein-Barr virus and the relationship to the C3d receptor.
Takimoto T; Sato H; Ogura H; Miyawaki T; Glaser R
Cancer Res; 1986 May; 46(5):2541-4. PubMed ID: 3008992
[TBL] [Abstract][Full Text] [Related]
6. Recovery of transforming EBV from non-producer cells after superinfection with non-transforming P3HR-1 EBV.
Fresen KO; Cho MS; zur Hausen H
Int J Cancer; 1978 Oct; 22(4):378-83. PubMed ID: 212377
[TBL] [Abstract][Full Text] [Related]
7. B cell activation by the nontransforming P3HR-1 substrain of the Epstein-Barr virus (EBV).
Hu CP; Aman P; Masucci MG; Klein E; Klein G
Eur J Immunol; 1986 Jul; 16(7):841-5. PubMed ID: 3013647
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of Epstein-Barr virus-encoded latent membrane protein by human herpesvirus 6 superinfection of EBV-carrying Burkitt lymphoma cells.
Cuomo L; Trivedi P; de Grazia U; Calogero A; D'Onofrio M; Yang W; Frati L; Faggioni A; Rymo L; Ragona G
J Med Virol; 1998 Jul; 55(3):219-26. PubMed ID: 9624610
[TBL] [Abstract][Full Text] [Related]
9. Transformation of rabbit lymphocytes by an Epstein-Barr virus-related herpesvirus from Macaca arctoides.
Meerbach A; Friedrichs C; Thust R; Wutzler P
Arch Virol; 2004 Jun; 149(6):1083-94. PubMed ID: 15168196
[TBL] [Abstract][Full Text] [Related]
10. Functional association of class II antigens with cell surface binding of Epstein-Barr virus.
Reisert PS; Spiro RC; Townsend PL; Stanford SA; Sairenji T; Humphreys RE
J Immunol; 1985 Jun; 134(6):3776-80. PubMed ID: 2985696
[TBL] [Abstract][Full Text] [Related]
11. Re-evaluation of a transforming strain of Epstein-Barr virus from the Burkitt lymphoma cell line, Jijoye.
Sairenji T; Hinuma Y
Int J Cancer; 1980 Sep; 26(3):337-42. PubMed ID: 6270005
[TBL] [Abstract][Full Text] [Related]
12. Growth and spread in nude mice of Epstein-Barr virus transformed B-cells from a chronic lymphocytic leukemia patient.
Lee CL; Uniyal S; Fernandez LA; Lee SH; Ghose T
Cancer Res; 1986 May; 46(5):2497-501. PubMed ID: 3008990
[TBL] [Abstract][Full Text] [Related]
13. Characterization of natural Epstein-Barr virus infection and replication in smooth muscle cells from a leiomyosarcoma.
Jenson HB; Montalvo EA; McClain KL; Ench Y; Heard P; Christy BA; Dewalt-Hagan PJ; Moyer MP
J Med Virol; 1999 Jan; 57(1):36-46. PubMed ID: 9890420
[TBL] [Abstract][Full Text] [Related]
14. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
Callahan J; Pai S; Cotter M; Robertson ES
Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337
[TBL] [Abstract][Full Text] [Related]
15. Human B cell line deficient in the expression of B cell-specific glycoproteins (GP 27,35).
Trowbridge IS; Hyman R; Klein G
Eur J Immunol; 1977 Sep; 7(9):640-5. PubMed ID: 72671
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Epstein-Barr virus (EBV) release from the P3HR-1 Burkitt's lymphoma cell line by a monoclonal antibody against a 200,000 dalton EBV membrane antigen.
Sairenji T; Reisert PS; Spiro RC; Connolly T; Humphreys RE
J Exp Med; 1985 May; 161(5):1097-111. PubMed ID: 2580934
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of adult bovine serum on release of infectious Epstein-Barr virus from a virus-carrier cell line.
Sairenji T; Hinuma Y
J Natl Cancer Inst; 1975 Aug; 55(2):339-43. PubMed ID: 169373
[TBL] [Abstract][Full Text] [Related]
18. [Studies on the synthesis of Epstein-Barr virus-related antigens induced by superinfection].
Fujiwara S
Hokkaido Igaku Zasshi; 1984 Sep; 59(5):586-602. PubMed ID: 6096242
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus (EBV) replication and expressions of EA-D (BMRF1 gene product), virus-specific deoxyribonuclease, and DNA polymerase in EBV-activated Akata cells.
Daibata M; Sairenji T
Virology; 1993 Oct; 196(2):900-4. PubMed ID: 8396819
[TBL] [Abstract][Full Text] [Related]
20. Multiplicity-dependent biological and biochemical properties of Epstein-Barr virus (EBV) rescued from non-producer lines after superinfection with P3HR-1 EBV.
Cho MS; Fresen KO; zur Hausen H
Int J Cancer; 1980 Sep; 26(3):357-63. PubMed ID: 6270006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
